SGEN Financial Facts

Investment income, net: 53K
Revenue from collaboration and license agreements: 22.22M
See Full Income Statement

Current portion of deferred revenue: 47.7M
Total stockholders' equity: 209.29M
See Full Balance Sheet

Seattle Genetics Inc. (SGEN) Earnings

  |   Expand Research on SGEN
Next EPS Date N/A EPS Growth Rate -69.2% *Last Qtr.
Average EPS % Beat Rate +33.8% Revenue Growth Rate +10.2% *Last Qtr.
Average % Move 1-Wk after EPS -0.8% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/10/15 Q414 -$0.22-$0.25 +$0.03$74.3M$68.34M N/A Details
10/30/14 Q314 -$0.13-$0.24 +$0.11$75.8M$66.9M N/A Details
7/31/14 Q214 -$0.14-$0.23 +$0.09$68.3M$65.04M N/A Details
5/1/14 Q114 -$0.13-$0.21 +$0.08$68.3M$64.62M N/A Details
2/11/14 Q413 -$0.13-$0.24 +$0.11$67.4M$59.5M N/A Details
11/5/13 Q313 -$0.19-$0.22 +$0.03$57.8M$57.79M N/A Details
7/31/13 Q213 -$0.06-$0.19 +$0.13$73.6M$57.15M N/A Details
5/7/13 Q113 -$0.14-$0.20 +$0.06$57.3M$53.72M N/A Details